Glee Biotech

Delhi, India Founded: 2020 • Age: 6 yrs
Develops and manufactures a range of pharmaceutical products, including generic and branded medications.
Request Access
Report Incorrect Data
Annual revenue $2.2M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Glee Biotech

Glee Biotech is a company based in Delhi (India) founded in 2020. It operates as a B2B. Glee Biotech operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

  • Headquarter Delhi, India
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Glee Biotech Limited
  • Date of Incorporation 03 Mar, 2020
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics → →
Key Metrics
  • Annual Revenue
    $2.21 M (USD)
    9.73
    as on Mar 31, 2023
  • Net Profit
    $331.69 K (USD)
    64.89
    as on Mar 31, 2023
  • EBITDA
    $633.19 K (USD)
    86.57
    as on Mar 31, 2023
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Glee Biotech

Investments & Acquisitions by Glee Biotech

Investments

Financial Statements - Glee Biotech

Glee Biotech Comparisons

+
Add Comparison
Available on Premium

Competitors of Glee Biotech

Glee Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company Name Domain Founded year HQ Location Description
Unither
domain founded_year HQ Location
Contract development and manufacturing organization for proprietary and generic drugs
Akums
domain founded_year HQ Location
CDMO focusing on spectrum of dosage forms and therapeutic segments
Jubilant Life Sciences
domain founded_year HQ Location
Company offering a suite of R&D and manufacturing services for small molecules and generics
Recipharm
domain founded_year HQ Location
Pharmaceutical development and manufacturing services are offered contractually.
CoreRx
domain founded_year HQ Location
CDMO with a focus on early phase drug product development
Nectar Lifesciences
domain founded_year HQ Location
Cephalosporin APIs and generic formulations are manufactured.

Latest news on Glee Biotech

Frequently Asked Questions about Glee Biotech

Glee Biotech was founded in 2020.

Glee Biotech is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Annual revenue of Glee Biotech is $2.21M as on Mar 31, 2023.

Glee Biotech develops and manufactures a range of pharmaceutical products, including generic and branded medications through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.

Glee Biotech's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available